Praxis Precision Medicines (PRAX) Operating Leases (2019 - 2024)

Praxis Precision Medicines' Operating Leases history runs 6 years deep, the most recent figure standing at $1.4 million for Q4 2024.

• In Q4 2024, Operating Leases changed 0.0% year-over-year to $1.4 million; the TTM figure through Dec 2024 stood at $1.4 million (changed 0.0% YoY), while the FY2024 annual figure was $1.4 million, changed 0.0% from the prior year.
• Operating Leases was $1.4 million for Q4 2024 at Praxis Precision Medicines, up from $436000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $4.3 million in Q4 2021 to a low of $198000.0 in Q3 2020.
• Historically, Operating Leases has averaged $2.2 million across 5 years, with a median of $1.9 million in 2023.
• The sharpest annual moves came in 2021 and 2024: Operating Leases jumped 2028.79% in 2021, then plunged 73.75% in 2024.
• A 5-year view of Operating Leases shows it stood at $763000.0 in 2020, then soared by 465.01% to $4.3 million in 2021, then dropped by 18.81% to $3.5 million in 2022, then slumped by 60.89% to $1.4 million in 2023, then changed by 0.0% to $1.4 million in 2024.
• The last three Operating Leases figures came in at $1.4 million (Q4 2024), $436000.0 (Q3 2024), and $755000.0 (Q2 2024), per Business Quant data.